CytoSpecial

CytoSpecial
Podcast Description
Sometimes, the most thought-provoking conversations happen beyond the office — in the lobby of a Palo Alto hotel, a coffee shop in Cambridge Mass, or even on the stunning beaches of Crete.When you connect with leading experts who share your passion for pharma and biotech, business and innovation, some really powerful ideas come to life.Welcome to CytoSpecial, a CytoReason production.
Podcast Insights
Content Themes
The podcast focuses on themes such as drug development, personalized medicine, and the intersection of AI and healthcare, with episodes discussing the impact of omics datasets, the challenges of innovation adoption in pharma, and strategies for data scaling in healthcare.

Sometimes, the most thought-provoking conversations happen beyond the office — in the lobby of a Palo Alto hotel, a coffee shop in Cambridge Mass, or even on the stunning beaches of Crete.
When you connect with leading experts who share your passion for pharma and biotech, business and innovation, some really powerful ideas come to life.
Welcome to CytoSpecial, a CytoReason production.
How will vast omics datasets and AI reshape drug development and personalized medicine?
How do you disrupt pharma’s systemic intertia and the industry’s cautious adoption of innovation?
How can more access to data scale the business and drive leadership in AI-driven healthcare?
CytoReason’s CEO, David Harel, and Candesic’s Managing Partner, Leonid Shapiro, come together to discuss these and other questions at the intersection of AI, data, and healthcare during CytoReason’s annual CytoSummit conference.

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.